Guardant Health’s Post

Mainz Biomed unveils consolidated findings from both ColoFuture and eAArly DETECT study. 92% sensitivity for Colorectal Cancer seems remarkable The study underscored the substantial advantage of the multimodal screening test compared to existing methods, especially in identifying advanced precancerous lesions. Notably, the sensitivity for detecting high-grade dysplasia, which carries a heightened risk of progressing to cancer, with the multimodal approach was 95.8%, markedly surpassing other non-invasive tests presently accessible. Unlock Expert Insights and In-Depth Analysis Exclusively with DelveInsight Business Research LLP at American Society of Clinical Oncology (ASCO) 2024 @ https://lnkd.in/guN-Vb79 #asco24 #asco #ascoconference #MainzBiomedFindings #ColoFutureStudy #eAArlyDETECT #ColorectalCancerScreening #MultimodalScreeningTest #CRCSensitivity #AdvancedPrecancerousLesions #HighGradeDysplasia #NonInvasiveTests #CancerPrevention #EarlyDetection #InnovativeDiagnostics #HealthcareAdvancements #ScreeningEffectiveness #BiomedicalResearch

Hear from subject matter experts Aasma Shaukat, MD, MPH, and Erin Peterson from the Colon Cancer Coalition as they address how to capture patient compliance for colorectal cancer screenings, gain early detection and improve patient outcomes. Watch now. #ColorectalCancer

New review suggests that while cancer screening might not always increase lifespan, colorectal cancer screening with sigmoidoscopy could be the exception. 🩺 Learn more about the latest findings in the JAMA Internal Medicine publication. #CancerScreening #HealthResearch #BloodTests #LabTests HealthOneLabs.com

New findings from CALGB/SWOG 80405: High HER2 expression in metastatic colorectal cancer significantly predicts longer progression-free and overall survival, influencing decision-making on bevacizumab vs cetuximab treatment. #CancerResearch #PrecisionMedicine #HealthcareInnovation

Hear from subject matter experts Aasma Shaukat, MD, MPH, and Erin Peterson from the Colon Cancer Coalition as they address how to capture patient compliance for colorectal cancer screenings, gain early detection and improve patient outcomes. Watch now. #ColorectalCancer

Hear from subject matter experts Aasma Shaukat, MD, MPH, and Erin Peterson from the Colon Cancer Coalition as they address how to capture patient compliance for colorectal cancer screenings, gain early detection and improve patient outcomes. Watch now. #ColorectalCancer

Hear from subject matter experts Aasma Shaukat, MD, MPH, and Erin Peterson from the Colon Cancer Coalition as they address how to capture patient compliance for colorectal cancer screenings, gain early detection and improve patient outcomes. Watch now. #ColorectalCancer

Hear from subject matter experts Aasma Shaukat, MD, MPH, and Erin Peterson from the Colon Cancer Coalition as they address how to capture patient compliance for colorectal cancer screenings, gain early detection and improve patient outcomes. Watch now. #ColorectalCancer

Join NCHPH in our upcoming webinar on colorectal cancer! In this webinar, we will take a practical, epidemiological view of the promotion and marketing of colorectal screening services. The session will include a review of validated promising practices, screening tools and marketing procedures that have been shown to increase rates of colorectal screening in populations of FQHC patients. #HealthCenters #PublicHousing #CHCs #FQHC #FQHCs

Hear from subject matter experts Aasma Shaukat, MD, MPH, and Erin Peterson from the Colon Cancer Coalition as they address how to capture patient compliance for colorectal cancer screenings, gain early detection and improve patient outcomes. Watch now. #ColorectalCancer